Latest News about XCUR
Recent news which mentions XCUR
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 18, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
January 14, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 03, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 03, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 16, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 14, 2021
From Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
December 14, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 14, 2021
From Benzinga
From InvestorPlace
20 Stocks Moving in Tuesday's Pre-Market Session
December 14, 2021
From Benzinga
Exicure Stock Plunges After Results Of Internal Probe, Management Shakeup, Layoffs
December 13, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 13, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2021
December 13, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 13, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 25, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 19, 2021
From Benzinga
80 Biggest Movers From Yesterday
November 17, 2021
From Benzinga
53 Stocks Moving In Tuesday's Mid-Day Session
November 16, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 16, 2021
From Benzinga
From InvestorPlace
36 Stocks Moving in Tuesday's Pre-Market Session
November 16, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
November 08, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 17, 2021
From Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 10, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.